Skip to main content

Event Details

Summit Therapeutics Presents at Citizens Life Sciences Conference

March 11, 2026 2:15 PM ET

*Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).

© Summit Therapeutics Inc.

Trademarks, Registered or Otherwise, are the property of their respective owner(s).